Cargando…
COVID-19 and hyperglycemia/diabetes
In early studies regarding coronavirus disease 2019 (COVID-19), type 2 diabetes mellitus was considered to contribute substantially to the disease’s inflammatory response. Subsequently, even hyperglycemia, regardless of insulin resistance or diabetes mellitus, was found to be additionally harmful. R...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107977/ https://www.ncbi.nlm.nih.gov/pubmed/33995851 http://dx.doi.org/10.4239/wjd.v12.i5.642 |
_version_ | 1783690048301957120 |
---|---|
author | Michalakis, Konstantinos Ilias, Ioannis |
author_facet | Michalakis, Konstantinos Ilias, Ioannis |
author_sort | Michalakis, Konstantinos |
collection | PubMed |
description | In early studies regarding coronavirus disease 2019 (COVID-19), type 2 diabetes mellitus was considered to contribute substantially to the disease’s inflammatory response. Subsequently, even hyperglycemia, regardless of insulin resistance or diabetes mellitus, was found to be additionally harmful. Recent studies have shown inflammation of the pancreatic β cells in COVID-19, even leading to new onset diabetes mellitus. We hereby summarize core literature on glycemia and COVID-19, and present implicated pathways and mechanisms. |
format | Online Article Text |
id | pubmed-8107977 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-81079772021-05-15 COVID-19 and hyperglycemia/diabetes Michalakis, Konstantinos Ilias, Ioannis World J Diabetes Minireviews In early studies regarding coronavirus disease 2019 (COVID-19), type 2 diabetes mellitus was considered to contribute substantially to the disease’s inflammatory response. Subsequently, even hyperglycemia, regardless of insulin resistance or diabetes mellitus, was found to be additionally harmful. Recent studies have shown inflammation of the pancreatic β cells in COVID-19, even leading to new onset diabetes mellitus. We hereby summarize core literature on glycemia and COVID-19, and present implicated pathways and mechanisms. Baishideng Publishing Group Inc 2021-05-15 2021-05-15 /pmc/articles/PMC8107977/ /pubmed/33995851 http://dx.doi.org/10.4239/wjd.v12.i5.642 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Minireviews Michalakis, Konstantinos Ilias, Ioannis COVID-19 and hyperglycemia/diabetes |
title | COVID-19 and hyperglycemia/diabetes |
title_full | COVID-19 and hyperglycemia/diabetes |
title_fullStr | COVID-19 and hyperglycemia/diabetes |
title_full_unstemmed | COVID-19 and hyperglycemia/diabetes |
title_short | COVID-19 and hyperglycemia/diabetes |
title_sort | covid-19 and hyperglycemia/diabetes |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107977/ https://www.ncbi.nlm.nih.gov/pubmed/33995851 http://dx.doi.org/10.4239/wjd.v12.i5.642 |
work_keys_str_mv | AT michalakiskonstantinos covid19andhyperglycemiadiabetes AT iliasioannis covid19andhyperglycemiadiabetes |